Erste Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Hold |
27,000
| – | – | 0.01% | 475 |
|
|
2025
Q1 | $800K | Hold |
27,000
| – | – | 0.01% | 396 |
|
|
2024
Q4 | $1.08M | Hold |
27,000
| – | – | 0.01% | 376 |
|
|
2024
Q3 | $1.31M | Hold |
27,000
| – | – | 0.02% | 362 |
|
|
2024
Q2 | $816K | Hold |
27,000
| – | – | 0.01% | 390 |
|
|
2024
Q1 | $1.08M | Hold |
27,000
| – | – | 0.01% | 362 |
|
|
2023
Q4 | $724K | Hold |
27,000
| – | – | 0.01% | 399 |
|
|
2023
Q3 | $386K | Hold |
27,000
| – | – | 0.01% | 431 |
|
|
2023
Q2 | $605K | Hold |
27,000
| – | – | 0.01% | 400 |
|
|
2023
Q1 | $763K | Hold |
27,000
| – | – | 0.01% | 394 |
|
|
2022
Q4 | $692K | Buy |
27,000
+16,000
| +145% | +$410K | 0.01% | 398 |
|
|
2022
Q3 | $243K | Hold |
11,000
| – | – | 0.01% | 484 |
|
|
2022
Q2 | $223K | Hold |
11,000
| – | – | 0.01% | 506 |
|
|
2022
Q1 | $457K | Buy |
+11,000
| New | +$457K | 0.01% | 444 |
|